Rosetta Genomics (Rosetta Genomics) Effective Interest Rate on Debt % : 0.00% (As of Jun. 2017)

View and export this data going back to 2007. Start your Free Trial

What is Rosetta Genomics Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Rosetta Genomics's annualized positive value of Interest Expense for the quarter that ended in Jun. 2017 was $0.00 Mil. Rosetta Genomics's average total debt for the quarter that ended in Jun. 2017 was $3.12 Mil. Therefore, Rosetta Genomics's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2017 was 0.00%.

Rosetta Genomics Effective Interest Rate on Debt % Historical Data

The historical data trend for Rosetta Genomics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rosetta Genomics Effective Interest Rate on Debt % Chart

Rosetta Genomics Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

1,063.33

1.13

Rosetta Genomics Quarterly Data
	Dec10	Mar11	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															-	-	45.55	112.19	-

Competitive Comparison of Rosetta Genomics's Effective Interest Rate on Debt %

For the Diagnostics & Research subindustry, Rosetta Genomics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rosetta Genomics's Effective Interest Rate on Debt % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rosetta Genomics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Rosetta Genomics's Effective Interest Rate on Debt % falls into.

Rosetta Genomics Effective Interest Rate on Debt % Calculation

Rosetta Genomics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2016 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2015 )	+	Total Debt (A: Dec. 2016 ))	/ count )
=	-1 * -0.043	/	( (0	+	3.795)	/ 1 )
=	-1 * -0.043	/	3.795
=	1.13 %

where

	Total Debt (A: Dec. 2015 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0
=	0

	Total Debt (A: Dec. 2016 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	3.74	+	0.055
=	3.795

Rosetta Genomics's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2017 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Dec. 2016 )	+	Total Debt (Q: Jun. 2017 ))	/ count )
=	-1 * 0	/	( (3.795	+	2.449)	/ 2 )
=	-1 * 0	/	3.122
=	0.00 %

where

	Total Debt (Q: Dec. 2016 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	3.74	+	0.055
=	3.795

	Total Debt (Q: Jun. 2017 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	2.394	+	0.055
=	2.449

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Jun. 2017) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Rosetta Genomics (OTCPK:ROSGQ) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Rosetta Genomics Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Rosetta Genomics's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rosetta Genomics (Rosetta Genomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rosetta Genomics Ltd (OTCPK:ROSGQ) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Plaut Street, Science Park, Rehovot, ISR, 76706

Website

http://www.rosettagenomics.com

Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.

Executives

Sabby Management, Llc	10 percent owner	115 HIDDEN HILLS DR, SPICEWOOD TX 78669
Sabby Healthcare Volatility Master Fund, Ltd.	10 percent owner	C/O SABBY MANAGEMENT, LLC, 10 MOUNTAINVIEW ROAD, SUITE 205, UPPER SADDLE RIVER NJ 07458

Rosetta Genomics (Rosetta Genomics) Headlines

From GuruFocus

Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS

By gurufocus • 12-09-2008